Adtalem Global Education Inc. Share Price

Equities

ATGE

US00737L1035

Miscellaneous Educational Service Providers

Market Closed - Nyse 01:30:02 05/06/2024 am IST 5-day change 1st Jan Change
65.2 USD -0.62% Intraday chart for Adtalem Global Education Inc. -1.42% +10.60%
Sales 2024 * 157.34Cr 13TCr Sales 2025 * 165.99Cr 14TCr Capitalization 245.19Cr 20TCr
Net income 2024 * 13Cr 1.11TCr Net income 2025 * 20Cr 1.7TCr EV / Sales 2024 * 1.87 x
Net Debt 2024 * 50Cr 4.13TCr Net Debt 2025 * 31Cr 2.57TCr EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 4,515
Yield 2024 *
-
Yield 2025 *
-
Free-Float 44.22%
More Fundamentals * Assessed data
Dynamic Chart
Barrington Raises Price Target on Adtalem Global Education to $70 From $65, Maintains Outperform Rating MT
Transcript : Adtalem Global Education Inc., Q3 2024 Earnings Call, May 02, 2024
Earnings Flash (ATGE) ADTALEM GLOBAL EDUCATION Reports Q3 EPS $1.50, vs. Street Est of $1.16 MT
Earnings Flash (ATGE) ADTALEM GLOBAL EDUCATION Posts Q3 Revenue $412.7M, vs. Street Est of $391.7M MT
Tranche Update on Adtalem Global Education Inc.'s Equity Buyback Plan announced on January 19, 2024. CI
Adtalem Global Education Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Adtalem Global Education Inc. Raises Revenue Guidance for the Fiscal Year 2024 CI
Transcript : Adtalem Global Education Inc. Presents at Morgan Stanley?s Technology, Media & Telecom Conference 2024, Mar-06-2024 01:20 PM
Adtalem Global Education Appoints Scott Liles as the New Medical and Veterinary President, Effective April 1, 2024 CI
Adtalem Global Education Refutes Safkhet Capital's Report -- Shares Up After Hours MT
Adtalem Global Education's Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Increased MT
Earnings Flash (ATGE) ADTALEM GLOBAL EDUCATION Posts Q2 Revenue $393.2M, vs. Street Est of $372.8M MT
Earnings Flash (ATGE) ADTALEM GLOBAL EDUCATION Reports Q2 EPS $1.23, vs. Street Est of $0.98 MT
Adtalem Global Education Inc. Revises Earnings Guidance for the Fiscal Year 2024 CI
Adtalem Global Education Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
More news
1 day-0.62%
1 week-1.42%
Current month+1.26%
1 month+8.52%
3 months+33.44%
6 months+9.80%
Current year+10.60%
More quotes
1 week
63.52
Extreme 63.52
66.11
1 month
59.35
Extreme 59.35
67.69
Current year
43.78
Extreme 43.775
67.69
1 year
33.59
Extreme 33.59
67.69
3 years
19.14
Extreme 19.14
67.69
5 years
19.14
Extreme 19.14
67.69
10 years
15.36
Extreme 15.36
67.69
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 01/18/01
Director of Finance/CFO 59 11/20/11
Director/Board Member 54 01/08/01
Members of the board TitleAgeSince
Director/Board Member 73 04/18/04
Director/Board Member 64 29/20/29
Director/Board Member 64 12/17/12
More insiders
Date Price Change Volume
04/24/04 65.2 -0.62% 358,092
03/24/03 65.61 +1.89% 436,672
31/24/31 64.39 -1.75% 425,985
30/24/30 65.54 +1.72% 304,068
29/24/29 64.43 -2.59% 245,557

Delayed Quote Nyse, June 05, 2024 at 01:30 am IST

More quotes
Adtalem Global Education Inc. is a provider of professional talent to the healthcare industry. The Company operates through three segments: Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment includes the operations of Chamberlain University (Chamberlain). Walden segment offers more than 100 online certificate, bachelor’s, master’s, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment includes the operations of the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
65.2 USD
Average target price
68.33 USD
Spread / Average Target
+4.81%
Consensus

Quarterly revenue - Rate of surprise